Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-22.63	27.40	35.41
Graham Fair Price	674.87	7418.38	957.37
PEG	-99.97	< 0.005	1.43
Price/Book	-6.95	0.21	0.23
Price/Cash Flow	574.51	17.95	2.66
Prices/Earnings	-98.40	2.21	-137.55
Price/Sales	0.55	0.27	0.27
Price/FCF	574.51	17.95	2.66
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	25.28	0.16	0.13
Operating Margin	54.16	0.08	0.05
ROA	5893.19	< 0.005	< 0.005
ROE	< 0.005	0.02	5700.83
ROIC	< 0.005	< 0.005	84.10
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.01	-0.02	35.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	5.27	0.45	-91.44
EPS QOQ	0.96	60.01	6141.02
FCF QOQ	1.02	-0.86	-15.81
Revenue QOQ	0.18	-0.06	-67.12
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	71.93	79.26	10.19
Days Sales Outstanding (DSO)	98.21	68.34	-30.42
Inventory Turnover	1.25	1.14	-9.25
Debt/Capitalization	0.77	0.76	-0.68
Quick Ratio	0.66	0.63	-4.87
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	9961.56	10134.74	1.74
Cash	6715.92	8805.00	31.11
Capex	-1638.94	-1004.62	38.70
Free Cash Flow	845.35	118.64	-85.97
Revenue	8444.17	7950.05	-5.85
Naive Interpretation	member

05 - Per Share Metrics · Weak

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	0.92	0.90	-2.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	32.84	25.46	-22.46
Naive Interpretation	Member

06 - Financial Health · Bad

Rating